This elevated ratio was consideredas a gold standard for clinical diagnosis of the disease(8) before the proposal of the Rotterdam criteria.However LH/FSH levels, as a gold standard,became controversial after a number of studieshave reported a variable prevalence of these ratios(30-90%) among PCOS women (9, 10). The gene discussed is BRD2; the disease is polycystic ovary syndrome.